| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 166,357 | 199,140 | 249,595 | 295,902 | | Cost of Revenue | 120,749 | 145,463 | 185,612 | 219,966 | | | Gross Profit | 45,608 | 53,677 | 63,983 | 75,936 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 36,933 | 37,840 | 50,080 | 55,176 | | Non Recurring | 6,200 | 2,152 | 178,625 |
-
| | Others | 3,495 | 3,442 | 3,467 | 3,581 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,020) | 10,243 | (168,189) | 17,179 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,020) | 10,243 | (168,189) | 17,179 | | Interest Expense | 2,063 | 2,320 | 2,199 | 2,669 | | Income Before Tax | (3,083) | 7,923 | (170,388) | 14,510 | | Income Tax Expense | (1,088) | 3,549 | (48,554) | 6,886 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,995) | 4,374 | (121,834) | 7,624 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,995) | 4,374 | (121,834) | 7,624 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,995) | $4,374 | ($121,834) | $7,624 |
|
1.52% Nasdaq 0.00%
Income Statement
